GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Embla Medical hf (OCSE:EMBLA) » Definitions » Days Sales Outstanding

Embla Medical hf (OCSE:EMBLA) Days Sales Outstanding : 58.83 (As of Mar. 2024)


View and export this data going back to 2009. Start your Free Trial

What is Embla Medical hf Days Sales Outstanding?

Embla Medical hf's average Accounts Receivable for the three months ended in Mar. 2024 was kr884 Mil. Embla Medical hf's Revenue for the three months ended in Mar. 2024 was kr1,371 Mil. Hence, Embla Medical hf's Days Sales Outstanding for the three months ended in Mar. 2024 was 58.83.

The historical rank and industry rank for Embla Medical hf's Days Sales Outstanding or its related term are showing as below:

OCSE:EMBLA' s Days Sales Outstanding Range Over the Past 10 Years
Min: 47.91   Med: 54.52   Max: 62.48
Current: 56.2

During the past 13 years, Embla Medical hf's highest Days Sales Outstanding was 62.48. The lowest was 47.91. And the median was 54.52.

OCSE:EMBLA's Days Sales Outstanding is ranked better than
60.47% of 807 companies
in the Medical Devices & Instruments industry
Industry Median: 64.21 vs OCSE:EMBLA: 56.20

Embla Medical hf's Days Sales Outstanding increased from Mar. 2023 (57.11) to Mar. 2024 (58.83).


Embla Medical hf Days Sales Outstanding Historical Data

The historical data trend for Embla Medical hf's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Embla Medical hf Days Sales Outstanding Chart

Embla Medical hf Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only 55.30 62.48 49.31 52.99 56.52

Embla Medical hf Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 57.11 53.98 57.85 55.06 58.83

Competitive Comparison of Embla Medical hf's Days Sales Outstanding

For the Medical Devices subindustry, Embla Medical hf's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Embla Medical hf's Days Sales Outstanding Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Embla Medical hf's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Embla Medical hf's Days Sales Outstanding falls into.



Embla Medical hf Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Embla Medical hf's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

Days Sales Outstanding (A: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2022 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (789.177 + 873.788) / 2 ) / 5369.986*365
=831.4825 / 5369.986*365
=56.52

Embla Medical hf's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

Days Sales Outstanding (Q: Mar. 2024 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2023 ) + Accounts Receivable (A: Mar. 2024 )) / count ) / Revenue (A: Mar. 2024 )*Days in Period
=( (873.788 + 893.983) / 2 ) / 1370.945*365 / 4
=883.8855 / 1370.945*365 / 4
=58.83

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Embla Medical hf  (OCSE:EMBLA) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Embla Medical hf Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Embla Medical hf's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


Embla Medical hf (OCSE:EMBLA) Business Description

Traded in Other Exchanges
Address
Grjothals 5, Reykjavik, ISL
Ossur hf is engaged in the design, development, manufacture, and sale of prosthetics and bracing & support products. The company's products improve mobility through technologies in the field of braces, supports, prosthetic limbs, and compression therapy. Its segments are the Bracing & Supports and Prosthetics segment. The bracing & support products are used to support joints and other body parts for therapeutic and preventative purposes. The Prosthetics segment includes artificial limbs and related products for individuals born without limbs. Its geographical segments are the Americas; Europe, the Middle East & Africa (EMEA); and the Americas & Asia-Pacific (APAC), of which the Americas generate nearly half of the company's revenue.

Embla Medical hf (OCSE:EMBLA) Headlines

No Headlines